Meditation may alter Alzheimer's blood markers in just one week
NCT ID NCT06210035
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether two types of belly-focus meditation, practiced 40 minutes daily for a week, could change blood markers linked to Alzheimer's disease in healthy adults aged 18-35. Participants provided blood samples and completed memory tests before and after the meditation period. The goal was to see if meditation could improve brain clearance of amyloid proteins, which are associated with Alzheimer's risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Belly-focus meditation with slow breathing
What this could lead to
If it works, this could point toward a simple, non-drug way to reduce Alzheimer's risk by improving brain clearance of harmful proteins.
What could go wrong
This is a very early, small study in healthy young adults, not people with Alzheimer's. The blood marker changes may not translate to real disease prevention or treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Southern California
Los Angeles, California, 90089, United States